1Y Close · As of Aug 26, 2026
S.Biomedics operates in the Pharmaceuticals sector.
Legal name: S.Biomedics Co., Ltd.
In fiscal year 2025, S.Biomedics (304360) reported revenue of 16.5 billion KRW, up 20.5% from 13.7 billion KRW a year earlier.
Operating profit was -8.3 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 239.3 billion KRW, with a P/B of 14.31.
These figures can be verified in the DART filing (receipt no. 20260324000025).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 16.5B | -8.3B | — |
| 2024 | 13.7B | -5.4B | -5.8B |
| 2023 | 13.1B | -6.0B | -9.3B |
Recent Filings
Large Shareholding Report (General)
전환가액의조정 (제5회차)
전환사채(해외전환사채포함)발행후만기전사채취득 (제5회차)
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-25 | Large Shareholding Report (General) |
| 2026-08-13 | 전환가액의조정 (제5회차) |
| 2026-08-13 | 전환사채(해외전환사채포함)발행후만기전사채취득 (제5회차) |
| 2026-08-13 | Semi-Annual Report (2026.06) |